kr
158.50
Apr 25
Business Description
Vitrolife AB
ISIN : SE0011205202
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.57 | |||||
Interest Coverage | 7.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.09 | |||||
Beneish M-Score | -3.72 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.2 | |||||
3-Year FCF Growth Rate | 15 | |||||
3-Year Book Growth Rate | 71.7 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.57 | |||||
9-Day RSI | 18.1 | |||||
14-Day RSI | 24.99 | |||||
6-1 Month Momentum % | 41.99 | |||||
12-1 Month Momentum % | -9.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.68 | |||||
Quick Ratio | 2.98 | |||||
Cash Ratio | 1.7 | |||||
Days Inventory | 101.7 | |||||
Days Sales Outstanding | 54.14 | |||||
Days Payable | 42.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.53 | |||||
Forward Dividend Yield % | 0.62 | |||||
5-Year Yield-on-Cost % | 0.53 | |||||
3-Year Average Share Buyback Ratio | -7.7 | |||||
Shareholder Yield % | 0.9 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.39 | |||||
Operating Margin % | 21.38 | |||||
Net Margin % | -109.63 | |||||
FCF Margin % | 21.61 | |||||
ROE % | -24.57 | |||||
ROA % | -19.82 | |||||
ROIC % | 4.22 | |||||
ROC (Joel Greenblatt) % | -412.06 | |||||
ROCE % | -19.23 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.3 | |||||
PB Ratio | 1.67 | |||||
Price-to-Free-Cash-Flow | 29.15 | |||||
Price-to-Operating-Cash-Flow | 27.76 | |||||
EV-to-EBIT | -6.22 | |||||
EV-to-EBITDA | -6.22 | |||||
EV-to-Revenue | 6.42 | |||||
EV-to-FCF | 30.65 | |||||
Price-to-Projected-FCF | 1.23 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | -16.07 | |||||
FCF Yield % | 3.54 | |||||
Forward Rate of Return (Yacktman) % | 5.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Ā
Total Annual Return % Ā
Vitrolife AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 3,499 | ||
EPS (TTM) (kr) | -28.33 | ||
Beta | 2.77 | ||
Volatility % | 40.86 | ||
14-Day RSI | 24.99 | ||
14-Day ATR (kr) | 6.683334 | ||
20-Day SMA (kr) | 182.075 | ||
12-1 Month Momentum % | -9.29 | ||
52-Week Range (kr) | 124.1 - 243.6 | ||
Shares Outstanding (Mil) | 135.45 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vitrolife AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vitrolife AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Vitrolife AB Frequently Asked Questions
What is Vitrolife AB(LTS:0YAY)'s stock price today?
When is next earnings date of Vitrolife AB(LTS:0YAY)?
Does Vitrolife AB(LTS:0YAY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |